Adolescent caffeine consumption and mammographic breast density in premenopausal women.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 19 12 2018
accepted: 28 05 2019
pubmed: 4 6 2019
medline: 27 3 2021
entrez: 2 6 2019
Statut: ppublish

Résumé

Previous studies suggest that coffee and caffeine intake may be associated with reduced breast cancer risk. To date, there is limited and inconsistent epidemiologic evidence for associations of adolescent diet with mammographic breast density, a strong and consistent predictor of breast cancer. We investigated the association of adolescent caffeine intake with mammographic density in premenopausal women. This study included 751 cancer-free women within the Nurses' Health Study II cohort. Percent breast density (PD), absolute dense (DA) and non-dense areas (NDA) were measured from digitized film mammograms using a computer-assisted thresholding technique; all measures were square root-transformed. Energy-adjusted adolescent caffeine intake was estimated using the data from a food frequency questionnaire. Information regarding breast cancer risk factors was obtained from questionnaires closest to the mammogram date. We used generalized linear regression to quantify associations of caffeine intake with breast density measures. In multivariable analyses, adolescent caffeine intake was not associated with any of the density phenotypes (caffeine 4th vs. 1st quartile: β = - 1.27, 95% CI - 4.62; 2.09, p-trend = 0.55 for percent density; β = - 0.21, 95% CI - 0.76, 0.34, p-trend = 0.65 for absolute dense area, and β = 0.23, 95% CI - 0.28, 0.74, p-trend = 0.50 for non-dense area). Additional adjustment of the models for body mass index at age 18 resulted in attenuation of the risk estimates. Our findings do not support the hypothesis that adolescent caffeine intake is associated with premenopausal mammographic breast density.

Identifiants

pubmed: 31152213
doi: 10.1007/s00394-019-02018-0
pii: 10.1007/s00394-019-02018-0
pmc: PMC6885099
mid: NIHMS1054432
doi:

Substances chimiques

Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1633-1639

Subventions

Organisme : NIH HHS
ID : CA175080
Pays : United States
Organisme : NIH HHS
ID : CA131332
Pays : United States
Organisme : NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA176726
Pays : United States
Organisme : NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA175080
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : Susan G. Komen for the Cure
ID : NA
Organisme : NIH HHS
ID : UM1 CA176726
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA131332
Pays : United States
Organisme : NIH HHS
ID : CA131332
Pays : United States
Organisme : NIH HHS
ID : CA175080
Pays : United States
Organisme : NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NIH HHS
ID : UM1 CA176726
Pays : United States
Organisme : Avon Foundation for Women
ID : NA
Organisme : Breast Cancer Research Foundation
ID : NA

Références

Breast Cancer Res. 2011 Oct 21;13(5):R100
pubmed: 22017857
J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87
pubmed: 17652278
Cancer. 2009 Jun 15;115(12):2765-74
pubmed: 19384973
Carcinogenesis. 2006 Feb;27(2):269-77
pubmed: 16081510
Antioxidants (Basel). 2013 Oct 15;2(4):230-45
pubmed: 26784461
Int J Cancer. 2015 Oct 15;137(8):1979-89
pubmed: 25885188
J Adolesc Health. 2008 May;42(5):512-8
pubmed: 18407047
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
Pharmacogenet Genomics. 2011 Oct;21(10):642-51
pubmed: 21750469
J Natl Cancer Inst. 1995 Nov 1;87(21):1622-9
pubmed: 7563205
Breast Cancer Res Treat. 2018 May;169(1):115-123
pubmed: 29340883
J Adolesc Health. 2013 May;52(5 Suppl):S30-5
pubmed: 23298994
Cancer Causes Control. 2019 Mar;30(3):281-290
pubmed: 30739240
Cancer Res. 2006 Feb 15;66(4):2476-82
pubmed: 16489055
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
Nutr Cancer. 2013;65(3):398-409
pubmed: 23530639
Breast Cancer Res Treat. 2015 Jan;149(2):479-87
pubmed: 25543181
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1174-83
pubmed: 26063478
Cancer. 1999 Jun 1;85(11):2400-9
pubmed: 10357411
J Pediatr. 2006 Feb;148(2):183-7
pubmed: 16492426
Obes Rev. 2016 Feb;17(2):95-107
pubmed: 26696565
Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):689-96
pubmed: 20200427
BMJ. 2014 Jun 10;348:g3437
pubmed: 24916719
J Natl Cancer Inst. 2011 May 4;103(9):744-52
pubmed: 21483019
Eur J Cancer Prev. 1996 Oct;5(5):319-27
pubmed: 8972250
Breast Cancer Res Treat. 2012 Nov;136(1):277-87
pubmed: 23053640
Breast Cancer Res. 2013;15(5):R100
pubmed: 24156623
J Clin Sleep Med. 2011 Aug 15;7(4):337-42
pubmed: 21897768
Surgery. 1986 Sep;100(3):482-8
pubmed: 3738767
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):651-660
pubmed: 28062399
Breast Cancer Res. 2003;5(3):R59-64
pubmed: 12631400
Breast Cancer Res. 2015 Jul 16;17:95
pubmed: 26174168
N Engl J Med. 1985 Oct 24;313(17):1044-9
pubmed: 4047106
Nat Rev Cancer. 2005 May;5(5):388-96
pubmed: 15864280
Int J Cancer. 2015 Apr 15;136(8):1909-20
pubmed: 25220168
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):151-60
pubmed: 10698475
Am J Epidemiol. 1983 Jun;117(6):651-8
pubmed: 6859020
Breast Cancer Res. 2015 Jan 31;17:15
pubmed: 25637171
Cancer Causes Control. 1995 Nov;6(6):499-506
pubmed: 8580297
Am J Epidemiol. 2005 Jan 1;161(1):89-97
pubmed: 15615919
J Nutr. 2006 Jan;136(1):166-71
pubmed: 16365077
Am J Clin Nutr. 2006 Jul;84(1):95-135
pubmed: 16825686

Auteurs

Lusine Yaghjyan (L)

Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA. lyaghjyan@ufl.edu.

Graham Colditz (G)

Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Institute for Public Health, Washington University in St. Louis, St. Louis, MO, USA.

Bernard Rosner (B)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Shannan Rich (S)

Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.

Kathleen Egan (K)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

Rulla M Tamimi (RM)

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH